Study real-world outcomes of IBD infliximab patients with the Anser TDM Test: Presentation by Prometheus using the Lynx GI data library
PALO ALTO, CA / ACCESSWIRE / January 17, 2024 / Lynx.MD, a provider of a comprehensive medical data intelligence platform, is honored to support our partner, Andrew Shim, Medical Affairs, Prometheus Laboratories Inc, poster presentation at the upcoming Crohn’s & Colitis Congress 2024 demonstrating the potential of therapeutic drug monitoring (TDM) to positively impact patient outcome with infliximab dose optimization.
Poster Session: Comparing Real-World Outcomes… Using TDM vs. Unoptimized Control Group
Presenter: Dr. Andrew Shim, Prometheus Laboratories Inc., University of Minnesota
When: Friday, January 26th, 7:00 PM – 8:00 PM Pacific
Venue: Bellagio, Las Vegas
Key points of interest:
This study was made possible through a powerful collaboration between Prometheus Laboratories Inc. and Lynx.MD, a leading real-world medical data platform. Leveraging Lynx.MD’s rich repository of de-identified clinical data within the Lynx.MD Trusted Data Environment, Prometheus researchers gained unparalleled access to real-world treatment patterns and outcomes in a diverse patient population. This unique partnership exemplifies the power of data-driven research in advancing personalized medicine and ultimately improving patient lives.
Don’t miss this opportunity to learn more about this potentially transformative approach to IBD care at the Crohn’s & Colitis Congress. Attend Dr. Shim’s presentation to discover how data-driven insights can inform IBD treatments.
Additional Information:
Contact:
Victoria Holl
Vp of Marketing
Lynx.MD
victoria@lynx.md
650-248-4262
SOURCE: Lynx MD
View the original press release on accesswire.com
KUALA LUMPUR, Malaysia, June 27, 2025 /PRNewswire/ -- Avio Health, a deep-tech company dedicated to advancing healthcare through data analytics and machine learning, today announced…
The 2025 Novo Nordisk Foundation Challenge Programme awards DKK 479 million to nine innovative projects that…
AMSTERDAM, June 26, 2025 /PRNewswire/ -- Vinamilk, Vietnam's leading dairy company, presented its science-driven innovation…
In the study of rare diseases and precision medicine, understanding gene expression in the spatial…
ARLINGTON, Va., June 26, 2025 /PRNewswire/ -- A new survey of 195 diagnostic imaging and…
FREMONT, Calif., June 26, 2025 /PRNewswire/ -- Ultima Genomics, a developer of an innovative new…